| 1 |
35396143 | In vivo detection of urokinase-type plasminogen activator receptor (uPAR) expression in arterial atherogenesis using [64Cu]Cu-DOTA-AE105 positron emission tomography (PET). | 2022 Mar 30 |
1 |
| 2 |
24955765 | uPAR targeted radionuclide therapy with (177)Lu-DOTA-AE105 inhibits dissemination of metastatic prostate cancer. | 2014 Aug 4 |
1 |
| 3 |
22213823 | Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion. | 2012 Jan |
3 |
| 4 |
22739362 | New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts. | 2012 Oct |
1 |
| 5 |
18676745 | Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET. | 2008 Aug 1 |
5 |
| 6 |
23166959 | 177Lu-Labeled DOTA-conjugated AE105 peptide (Asp-Cha-Phe-(d)Ser-(d)Arg-Tyr-Leu-Trp-Ser-CONH2) | 2004 |
2 |